Schedule 13G ownership disclosure

Nabriva Therapeutics AG

Security class unavailable · CUSIP: 62957M104

Event date: 2015-09-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.7800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-15-331175
Form type
SC 13G
Filer
Global Life Bioventure IV S.a.r.l.
CIK
CIK 1652769
Filed
Sep 29, 2015
Reporting period
Sep 17, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub